Skip to content

Wednesday, December 18, 2024

Latest:

Mapping functional relations among proteins and genes helps illuminate their role in cancer
Occupational therapy: what patients need to know
Holly jolly health tips for Santa (and you)
Championing better care for adolescents with iron deficiency: Highlighting the impact of quality improvement initiatives
SPACe: A new open-source platform that supports large imaging data analysis on standard computers

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

resistance to cancr treatment

Interferon linked to ER+/HER- metastatic breast cancer resistance to therapy

March 12, 2021 CDK4/6 inhibitor therapy, endocrine therapy, ER+/HER2- breast cancer, Interferon, Metastatic breast cancer, Research, resistance to cancr treatment

Both preclinical models and tumor samples from patients with ER+/HER2- breast cancer link high IFN signaling to resistance to treatment.

From the Labs: Image of the Month

From the Labs: Humans are complex genetic mosaics.

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951